Occlutech

Occlutech is a leading provider of minimally invasive structural heart disease devices. Occlutech develops, manufactures, and commercializes structural heart and interatrial shunt products to improve the treatment of patients. Occlutech has a broad and proven portfolio, with more than 135,000 products sold, addressing congenital defects, stroke prevention and heart failure. Occlutech markets and sells its structural heart and interatrial shunt products to hospitals and clinics in approximately 85 countries through its direct sales organization and international network of distribution partners. Occlutech has approximately 250 employees and maintains manufacturing and R&D facilities in Jena, Germany and Istanbul, Turkey, with a global supply and customer support hub located in Helsingborg, Sweden.